Case report: Electrocardiographic changes in pembrolizumab-induced fatal myocarditis

Case report: Electrocardiographic changes in pembrolizumab-induced fatal myocarditis

Immune checkpoint inhibitor (ICI)-induced myocarditis is rare but fatal. Because of the rapid course of ICI-induced myocarditis, understanding of clinical course is only possible through information from case reports. We report a case of pembrolizumab-induced myocarditis in which we were able to doc...

Full description

Bibliographic Details
Main Authors: Kazuhiro Nishiyama, Kei Morikawa, Yusuke Shinozaki, Junko Ueno, Satoshi Tanaka, Hajime Tsuruoka, Shinya Azagami, Atsuko Ishida, Nobuyuki Yanagisawa, Yoshihiro J. Akashi, Masamichi Mineshita
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
irAE
lung cancer
myocarditis
pembrolizumab
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1078838/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1078838/full

Similar Items